XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Capital in Excess of Par Value [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Noncontrolling Interests [Member]
Beginning balance at Dec. 31, 2021 $ 8,560.1 $ 208.5 $ 6,143.7 $ 2,882.3 $ (726.1) $ 51.7
Beginning balance (in shares) at Dec. 31, 2021   208.5        
Net earnings 439.1     438.7   0.4
Net purchase of subsidiary shares from noncontrolling interests 2.1         2.1
Dividends paid to noncontrolling interests (0.6)         (0.6)
Net change in pension asset/liability, net of taxes 0.3       0.3  
Foreign currency translation 15.0       14.9 0.1
Change in fair value of derivative instruments, net of taxes 45.2       45.2  
Compensation expense related to stock option plan grants 5.7   5.7      
Stock option plans 37.8 $ 0.7 37.1      
Stock option plans (in shares)   0.7        
Employee stock purchase plan 8.1 $ 0.1 8.0      
Employee stock purchase plan (in shares)   0.1        
Shares issued to benefit plans 74.4 $ 0.5 73.9      
Shares issued to benefit plans (in shares)   0.5        
Deferred compensation and restricted stock (36.1) $ 0.3 (36.4)      
Deferred compensation and restricted (in shares)   0.3        
Cash dividends declared on common stock (108.0)     (108.0)    
Ending balance at Mar. 31, 2022 9,043.1 $ 210.1 6,232.0 3,213.0 (665.7) 53.7
Ending balance, (in shares) at Mar. 31, 2022   210.1        
Beginning balance at Dec. 31, 2022 $ 9,190.2 $ 211.9 6,509.9 3,562.2 (1,140.4) 46.6
Beginning balance (in shares) at Dec. 31, 2022 211.9 211.9        
Net earnings $ 486.6     486.5   0.1
Net purchase of subsidiary shares from noncontrolling interests (5.4)         (5.4)
Dividends paid to noncontrolling interests (0.7)         (0.7)
Net change in pension asset/liability, net of taxes 0.8       0.8  
Foreign currency translation 33.2       33.3 (0.1)
Change in fair value of derivative instruments, net of taxes 4.9       4.9  
Compensation expense related to stock option plan grants 7.7   7.7      
Common stock issued in: purchase transactions 186.5 $ 1.0 185.5      
Common stock issued in: purchase transactions (in shares)   1.0        
Stock option plans $ 21.2 $ 0.5 20.7      
Stock option plans (in shares) 0.6 0.5        
Employee stock purchase plan $ 9.1 $ 0.1 9.0      
Employee stock purchase plan (in shares)   0.1        
Shares issued to benefit plans 84.6 $ 0.4 84.2      
Shares issued to benefit plans (in shares)   0.4        
Deferred compensation and restricted stock (41.9) $ 0.3 (42.2)      
Deferred compensation and restricted (in shares)   0.3        
Cash dividends declared on common stock (118.5)     (118.5)    
Ending balance at Mar. 31, 2023 $ 9,858.3 $ 214.2 $ 6,774.8 $ 3,930.2 $ (1,101.4) $ 40.5
Ending balance, (in shares) at Mar. 31, 2023 214.2 214.2